Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surveillance of ischemic stroke recurrence after prescription of Efient (prasugrel) using JMDC claims data
jRCT2031230289Active, not recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of prasugrel and clopidogrel in ischemic stroke (2 cohorts), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Ischemic stroke recurrence. Started Jan 2005; status: active, not recruiting.
02
Drugs
prasugrelclopidogrel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on jRCT2031230289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230289.